CLINICAL_TRIALS
trial_result
· 2013-09-26
Clinical Trial Update: Evaluation of the Efficacy and Safety of NAFT-600 in Subjects With Tinea Pedis [Phase 3]
Summary
Phase 3 trial update evaluating NAFT-600 for efficacy and safety in treating tinea pedis. Results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merz North America, Inc. | Conditions: Tinea Pedis | Phase 3 | Status: COMPLETED | Results posted: 2013-09-26